Antiviral Drugs Advisory Committee Meetings FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - Antiviral Drugs Advisory Committee Meetings List of Tentative Meeting Dates for All CDER Advisory Committees List of Committee Members Committee Charter CDER Contacts Current Year Meeting Information 2004 FDA Advisory Committee Calendar -Meeting information includes center, date, time and...
http://www.fda.gov/cder/orange/appendix_a.txt 3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...
Approved Biotechnology Drugs, 2002 A --- B --- C --- D --- E --- F --- G --- H --- I --- K --- L --- M --- N --- O --- P --- R --- S --- T --- U --- V --- W --- X --- Z --- - Product (Bold text indicates recombinant and monoclonal antibody products) Company - Application (use) - Approval Date (FDA) Abelcet® (liposomal formulation of amphotericin B) - Enzon - Treatment of invasive fungal...
BIO Editors &Reporters 03LIVE page 54
author: Elinor
Prescription and OTC Drug Product List 6/1999 Prescription and Over-the-Counter Drug Product List - 19th Edition Cumulative Supplement Number 6: June 1999 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE AMINO ACIDS TABLET; ORAL INJECTABLE; INJECTION PERCOCET NOVAMINE 8.5% - ADD - AA ENDO PHARMS 325MG;5MG N40330 002 - DLT - @ PHARMACIA AND UPJOHN 8.5% N17957 002...
Prescription and OTC Drug Product List 2/2001 Prescription and Over-the-Counter Drug Product List - 21st Edition Cumulative Supplement Number 2: January-February 2001 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL AMOXICILLIN CAPSULE; ORAL CAPSULE; ORAL - DLT - TRIAPRIN AMOXICILLIN - DLT - DUNHALL 325MG;50MG N89268 001 - DLT - AB LABS ATRAL 250MG N62528 001 - DLT - JUL 02,...
Drug Approvals November 1996 Drug Approvals for November 1996 Definitions and Notes November 1996 Original New Drug Applications Original Application #: 020397 Approval Date: 27-NOV-96 Trade Name: ZANAFLEX Chemical Type: 1 Therapeutic Potential: S Dosage Form: TABLET Applicant: ATHENA NEUROSCIENCES INC Active Ingredient(s): TIZANIDINE HYDROCHLORIDE OTC/RX Status: RX Indication(s): For the acute and intermittent...
Drug Approvals for August 1997 Drug Approvals for August 1997 Definitions and Notes August 1997 Original New Drug Applications Original Application #: 020808 Approval Date: 29-AUG-97 Trade Name: VISIPAQUE Chemical Type: 3 Therapeutic Potential: S Dosage Form: INJECTABLE Applicant: NYCOMED INC Active Ingredient(s): IODIXANOL OTC/RX Status: RX Indication(s): Intra-arterial - for visceral intra-arterial digital...
BioPortfolio Limited 25 Associated pharmaceutical markets and indications 28 HIV 28 Cancer 28 Transplant 29 Others 29 CHAPTER 3 GLOBAL MARKET OVERVIEW 30 Key findings 30 Global antifungal market analysis 30 Superficial antifungal market analysis 32 Volume analysis 35 Systemic antifungal market analysis 36 Country analysis 39 Volume analysis 40 Seasonality 42 Global market forecast 44 Country forecasts 46...
PDF_JAN-FEB-07_newsletter.pdf See "Products" on Pages 2 & 3 For those who visit the Samaritan Pharmaceuticals Website, from time to time, get ready for something completely different to flash on your screen.
author: OEM
PDF_JAN-FEB-07_newsletter.pdf page 2
author: OEM
PDF_JAN-FEB-07_newsletter.pdf page 1
author: OEM
